DLA Piper advises Medtronic on USD3.5 billion ECP programme
3.03.2020Company: DLA Piper Prague LLP
DLA Piper has advised Medtronic Global Holdings S.C.A. (Medtronic LuxCo) on its entry into a USD3,5 billion Euro-Commercial Paper (ECP) programme on 31 January 2020, guaranteed by Medtronic PLC and Medtronic, Inc.
Barclays Bank Ireland PLC, Barclays Bank PLC, BofA Merrill Lynch International and Citigroup Global Markets Limited acted as dealers and Deutsche Bank AG, London Branch, as issue and paying agent under the ECP programme.
The DLA Piper Luxembourg-based team was led by Finance, Projects & Restructuring partner Laurent Massinon, who was supported by legal advisor Christina Nickel and associate Cindy van Rossum. Partner Jacques Wantz, and associates Emre Akan and Cyril Poels advised on the tax aspects of the transaction.
Headquarter in Dublin, Medtronic plc is among the world’s largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. Medtronic is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Tags: Law |
